Trials / Recruiting
RecruitingNCT06415435
Sylfirm X Radiofrequency Microneedling for the Treatment of Melasma
A Multi-Center, Open-Label, Prospective Study of the Sylfirm X Device for the Treatment of Melasma
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Benev Company, Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Microneedling radiofrequency technology has been shown in clinical studies to improve skin quality, tone, pigment, and to treat various skin conditions related to aging. The purpose of this study is to evaluate efficacy and safety of Sylfrim X device for the treatment of melasma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Radiofrequency Microneedling | Sylfirm X radiofrequency microneedling device |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2024-07-01
- Completion
- 2024-10-01
- First posted
- 2024-05-16
- Last updated
- 2024-05-16
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06415435. Inclusion in this directory is not an endorsement.